leisure time -WSS

leisure time

author：comprehensive 2025-09-06 03:55:00 - browse：59

STAT Q&A — Paul Matteis (right), in 2017 with then-colleagues Seamus Fernandez (far left) Geoffrey Porges. Alex Hogan/STAT

NEW YORK — Is biotech having a renaissance in neuroscience? Can we solve the placebo effect? And what’s going to happen next year?

Paul Matteis, co-head of biotech research at Stifel, sat down with STAT at the firm’s annual health care conference here to field those questions and opine on how management teams can walk the delicate balance between hype and sandbagging. This transcript has been edited for length and clarity.

One thing I’ve been hearing lately is that biotech has entered a sort of renaissance in neuroscience. Do you agree with that?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： FDA gives detailed accounting of AI

Wikipedia

WSS

FDA warns J&J's Abiomed: We will regulate your software

A former Republican legislative candidate has been charged for his role in the US Capitol riot

The explosion of genetic testing requires a new approach

Lawmakers consider Medicare pay reforms for doctors

HHS leader on health, climate change and biopharma emissions

Beam Therapeutics to lay off 20% of its staff, re

focus

leisure time

hotspot

Psychedelics group wrestles with new pharma identity

Trump Organization, Michael Cohen agree to settle million

The high cost of giving birth even with insurance

The explosion of genetic testing requires a new approach

Wildfire smoke exposes gaps in outdoor worker protections

EMA weighs against approval for Mirati's lung cancer drug

As demand for Covid shots wanes, Moderna seeks its next success

Trump Organization, Michael Cohen agree to settle million

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

FDA gives detailed accounting of AI

entertainment

Biden White House, tech companies launch new safeguards around emerging AI technology

Prosecutors say FTX founder Sam Bankman

A former Republican legislative candidate has been charged for his role in the US Capitol riot

2023 STAT Wunderkinds: get to know the winners

First Opinion Podcast: Long Covid needs a new approach

Listen: BridgeBio's big week & Lilly's Alzheimer's data

knowledge

hotspot

Wikipedia

Wikipedia